Dermgentle Seborrheic Face Cream
NDC Package 87261-100-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Dermgentle Seborrheic Face Cream (pyrithione zinc) cream is for the relief of the symptoms of seborrheic dermatitis such as skin flaking, redness, irritation and itching. This formulation utilizes a cream delivery system. Marketed by Dermgentle Llc, this product is identified by NDC 87261-100 and is authorized under FDA application M032.

Identification & Billing

NDC Package Code
87261-100-01
Package Description
57 g in 1 JAR
Product Code
87261-100
11-Digit Billing Format
87261010001
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Dermgentle Seborrheic Face Cream
Non-Proprietary Name
Pyrithione Zinc
Substance Name
Pyrithione Zinc
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
PYRITHIONE ZINC 1 mg/g
Usage Information
For the relief of the symptoms of seborrheic dermatitis such as skin flaking, redness, irritation and itching.

Regulatory & Marketing

Labeler Name
Dermgentle Llc
Product Type
Human Otc Drug
FDA Application #
M032
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-12-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87261-100-01 identifies a specific commercial package of 57 g in 1 jar of Dermgentle Seborrheic Face Cream, a human over the counter drug labeled by Dermgentle Llc. This cream is formulated for topical use and contains pyrithione zinc as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dermgentle Llc on December 12, 2025. The current certification is valid through December 31, 2026.

How is this Dermgentle Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87261010001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87261-100-01
11-Digit CMS (5-4-2)
87261-0100-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.